# Effects Of Dutasteride On Risk Reduction Of Acute Urinary Retention Relapse Following Trial Without Catheter

> **NCT00421421** · PHASE4 · TERMINATED · sponsor: **GlaxoSmithKline** · enrollment: 276 (—)

## Conditions studied

- Benign Prostatic Hyperplasia

## Interventions

- **DRUG:** Dutasteride

## Key facts

- **NCT ID:** NCT00421421
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-03
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 276 (—)
- **Why stopped:** Incomplete information
- **Last updated:** 2007-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00421421

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00421421, "Effects Of Dutasteride On Risk Reduction Of Acute Urinary Retention Relapse Following Trial Without Catheter". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT00421421. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*